Cite

HARVARD Citation

    Peng, Y. et al. (2022). TIGIT/CD47 dual high expression predicts prognosis and is associated with immunotherapy response in lung squamous cell carcinoma. Thoracic cancer. 13 (14), pp. 2014-2023. [Online]. 
  
Back to record